Nguyen Tuan 4/A
4/A · Arbutus Biopharma Corp · Filed Apr 1, 2025
Insider Transaction Report
Form 4/AAmended
Nguyen Tuan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-31+750,000→ 750,000 totalExercise: $3.49Exp: 2035-03-31→ Common Shares (750,000 underlying)
Footnotes (2)
- [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.
- [F2]This option vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.